M. Tomasi

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

Francisco J. Medrano, S. Brunak, V. Moreno, 2022, Human molecular genetics.

New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations

M. Nöthen, S. Brunak, V. Moreno, 2021, medRxiv.

Rare ATG7 genetic variants predispose patients to severe fatty liver disease.

L. N. Valenti, H. Reeves, V. Vaira, 2022, Journal of hepatology.

PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date

A. Cherubini, Luca Valenti, E. Casirati, 2021, Expert opinion on therapeutic targets.

Circulating Interlukin-32 and Altered Blood Pressure Control in Individuals with Metabolic Dysfunction

S. Pelusi, S. Romeo, A. Cherubini, 2023, International journal of molecular sciences.

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

V. Kärjä, J. Pihlajamäki, V. Männistö, 2024, Cell reports. Medicine.

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

M. Buti, J. Barretina, P. Rosenstiel, 2022, Human Molecular Genetics.